Siemens Healthineers is a global medical technology company headquartered in Erlangen, Germany. Recently, the company has been actively forging large-scale collaborations with healthcare providers both locally and worldwide, including the USA, Canada, and Saudi Arabia. Now it has also added Southeast Asia to this list, initiating a first-of-its-kind partnership in the region.
On April 28th, Siemens Healthineers entered a 5-year strategic alliance worth $23.9 million (SGD 32 million) with Singapore’s Health Management International (HMI Group) to advance healthcare in Southeast Asia. This Value Partnership, as they call them, enables partners to optimize business processes, expand capabilities, and advance innovation.
“At Siemens Healthineers, we understand the challenges that healthcare providers face in meeting the demand of providing quality healthcare. We are delighted to have signed this strategic partnership with HMI Group, which is first such for us in Southeast Asia,” said Mr. Fabrice Leguet, Managing Director and Head of Siemens Healthineers, Southeast Asia.
“We will not only provide our innovative technology and digital solutions, but also support HMI Group to create value through enhanced training programs and provide healthcare consulting to further develop Centres of Excellence (CoEs) in the areas of cancer, neuroscience, and cardiovascular. This will further position HMI Group as a leading quality healthcare provider in the region,” he added.
Quest for Healthcare Innovation
HMI Group is a leading regional private healthcare services provider that is further expanding across Singapore and Malaysia. The company is part of the Enterprise Singapore (ESG)’s 12-18 months program called Scale-up SG. The company has already shown immense progress in digital transformation and community engagement to accelerate growth.
“This strategic partnership will enable HMI Group’s medical facilities to improve patient care by serving as flagship reference sites for Siemens Healthineers in Southeast Asia,” said Ms. Chin Wei Jia, Group CEO of HMI Group. “As the care of our patients is at the center of everything that we do, our partnership will accelerate the adoption of connected health, thereby providing faster access to care, while building telehealth and predictive analytics capabilities at scale, all of which will go a long way in enhancing our patients’ journey towards a healthier outcome.”
Non-communicable diseases such as cancer, cardiovascular disorders, and diabetes account for 62% of all deaths in Southeast Asia. Among Singapore, Malaysia, and Indonesia, this number increases to 74%. HMI Group aims to transform healthcare by boosting the adoption of digital health, big data, and precision diagnosis. With the latest deal, it would focus further on bolstering healthcare facilities, digitalization, and develop local talent.
©www.geneonline.news. All rights reserved. Collaborate with us: email@example.com